Page last updated: 2024-10-25

clomipramine and Blindness

clomipramine has been researched along with Blindness in 1 studies

Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.

Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schlingemann, RO1
Smit, AA1
Lunel, HF1
Hijdra, A1

Other Studies

1 other study available for clomipramine and Blindness

ArticleYear
Amaurosis fugax on standing and angle-closure glaucoma with clomipramine.
    Lancet (London, England), 1996, Feb-17, Volume: 347, Issue:8999

    Topics: Antidepressive Agents, Tricyclic; Blindness; Clomipramine; Depression; Female; Glaucoma, Angle-Closu

1996